tirzepatide a semaglutide versus Once Weekly in Patients with Type 2 Diabetes transitioning from semaglutide to tirzepatide

However, if you are taking other medications alongside semaglutide, understanding the interaction landscape is important

[109] found no increased risk of pulmonary aspiration during upper gastrointestinal endoscopy in GLP-1 RA users versus those on sodium-glucose co-transporter 2 (SGLT2) inhibitors

For consumers, this means the first question is not Do I have hypothyroidism? but What kind of thyroid history do I actually have? A person whose hypothyroidism is stable on their thyroid hormone replacement medication may still be a candidate for GLP-1 or GLP-1/GIP treatment, especially if obesity or diabetes is also part of the picture

2007a;13(1):22-28

The treatment is performed in a clinic via an intravenous drip for only 15-20 minutes